Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model
- PMID: 22002997
- PMCID: PMC3276287
- DOI: 10.1093/hmg/ddr474
Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model
Abstract
Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disease caused by expansion of a CAG repeat encoding a polyglutamine tract in ATXN7, a component of the SAGA histone acetyltransferase (HAT) complex. Previous studies provided conflicting evidence regarding the effects of polyQ-ATXN7 on the activity of Gcn5, the HAT catalytic subunit of SAGA. Here, we report that reducing Gcn5 expression accelerates both cerebellar and retinal degeneration in a mouse model of SCA7. Deletion of Gcn5 in Purkinje cells in mice expressing wild-type (wt) Atxn7, however, causes only mild ataxia and does not lead to the early lethality observed in SCA7 mice. Reduced Gcn5 expression strongly enhances retinopathy in SCA7 mice, but does not affect the known transcriptional targets of Atxn7, as expression of these genes is not further altered by Gcn5 depletion. These findings demonstrate that loss of Gcn5 functions can contribute to the time of onset and severity of SCA7 phenotypes, and suggest that non-transcriptional functions of SAGA may play a role in neurodegeneration in this disease.
© The Author 2011. Published by Oxford University Press. All rights reserved.
Figures






Similar articles
-
The Molecular Basis of Spinocerebellar Ataxia Type 7.Front Neurosci. 2022 Mar 24;16:818757. doi: 10.3389/fnins.2022.818757. eCollection 2022. Front Neurosci. 2022. PMID: 35401096 Free PMC article. Review.
-
Direct inhibition of Gcn5 protein catalytic activity by polyglutamine-expanded ataxin-7.J Biol Chem. 2013 Nov 22;288(47):34266-34275. doi: 10.1074/jbc.M113.487538. Epub 2013 Oct 15. J Biol Chem. 2013. PMID: 24129567 Free PMC article.
-
Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8472-7. doi: 10.1073/pnas.0503505102. Epub 2005 Jun 2. Proc Natl Acad Sci U S A. 2005. PMID: 15932940 Free PMC article.
-
SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.J Neurosci. 2021 Jun 2;41(22):4910-4936. doi: 10.1523/JNEUROSCI.1882-20.2021. Epub 2021 Apr 22. J Neurosci. 2021. PMID: 33888607 Free PMC article.
-
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.Neurotherapeutics. 2019 Oct;16(4):1074-1096. doi: 10.1007/s13311-019-00778-5. Neurotherapeutics. 2019. PMID: 31432449 Free PMC article. Review.
Cited by
-
The Molecular Basis of Spinocerebellar Ataxia Type 7.Front Neurosci. 2022 Mar 24;16:818757. doi: 10.3389/fnins.2022.818757. eCollection 2022. Front Neurosci. 2022. PMID: 35401096 Free PMC article. Review.
-
Genetic syndromes caused by mutations in epigenetic genes.Hum Genet. 2013 Apr;132(4):359-83. doi: 10.1007/s00439-013-1271-x. Epub 2013 Jan 31. Hum Genet. 2013. PMID: 23370504 Review.
-
Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease.Epigenomics. 2012 Apr;4(2):163-77. doi: 10.2217/epi.12.3. Epigenomics. 2012. PMID: 22449188 Free PMC article. Review.
-
Polyglutamine-expanded ATXN7 alters a specific epigenetic signature underlying photoreceptor identity gene expression in SCA7 mouse retinopathy.J Biomed Sci. 2022 Dec 20;29(1):107. doi: 10.1186/s12929-022-00892-1. J Biomed Sci. 2022. PMID: 36539812 Free PMC article.
-
The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3.Mol Cell Proteomics. 2014 Nov;13(11):2896-910. doi: 10.1074/mcp.M114.038174. Epub 2014 Aug 8. Mol Cell Proteomics. 2014. PMID: 25106422 Free PMC article.
References
-
- David G., Abbas N., Stevanin G., Durr A., Yvert G., Cancel G., Weber C., Imbert G., Saudou F., Antoniou E., et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 1997;17:65–70. - PubMed
-
- David G., Durr A., Stevanin G., Cancel G., Abbas N., Benomar A., Belal S., Lebre A.-S., Abada-Bendib M., Grid D., et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7) Hum. Mol. Genet. 1998;7:165–170. - PubMed
-
- Del-Favero J., Krols L., Michalik A., Theuns J., Löfgren A., Goossens D., Wehnert A., Van den Bossche D., Van Zand K., Backhovens H., et al. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA Type II) caused by CAG triplet repeat expansion. Hum. Mol. Genet. 1998;7:177–186. - PubMed
-
- Johansson J., Forsgren L., Sandgren O., Brice A., Holmgren G., Holmberg M. Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation. Hum. Mol. Genet. 1998;7:171–176. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases